Gastroretentive extended release dosage form
A novel orally administrable dosage form including a drug/active layer for loading a therapeutic agent and an extension layer for retaining the API or drug dosage form in the stomach of a subject in need thereof. Also disclosed is a method of treating diseases with the dosage form.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
19.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A novel orally administrable dosage form including a drug/active layer for loading a therapeutic agent and an extension layer for retaining the API or drug dosage form in the stomach of a subject in need thereof. Also disclosed is a method of treating diseases with the dosage form. |
---|---|
Bibliography: | Application Number: US202318177348 |